Christopher Jewell, an assistant professor in the University of Maryland Fischell Department of Bioengineering, was awarded a three-year, $250,000 grant from the Alliance for Cancer Gene Therapy to develop gene therapy to promote cancer immunity, the university and the alliance announced Monday.
Jewell's research could create vaccine "depots" among the lymph nodes, specialized tissues that control responses against disease and infection.
The alliance is a nonprofit that sponsors promising research into cell and gene therapies to battle cancer. Jewell is one of two grant recipients this year and among 46 since 2001 from the alliance, which has a goal of replacing radiation, chemotherapy and surgery, while turning cancer into a manageable, treatable disease.
The Stamford, Conn.-based group has handed out more than $25 million in funding for the cause.